

Retatrutide 30 MG
Extended-quantity 30 MG triple incretin receptor agonist peptide for high-throughput laboratory research protocols.
Available to order
### Extended Quantity Triple Agonist for Quantitative Research
Retatrutide (30 MG) provides a larger peptide mass tailored for laboratories conducting multi-plate assays, longitudinal stability testing, or high-throughput receptor binding trials.
Formulated with the same verified high-purity single-peak synthesis (?99.2% by RP-HPLC) and vacuum-sealed in heavy-duty type-I borosilicate glass vials.
### Receptor Activity & Research Focus
• **Tri-Agonist Potency**: Balanced affinity across human GIP, GLP-1, and glucagon receptor lines.
• **Laboratory Investigations**: Longitudinal peptide clearance kinetics, comparative receptor saturation assays, and cyclic AMP (cAMP) accumulation modeling.
### Chemical Specifications
• **Purity**: ?99.2% (RP-HPLC)
• **Molecular Weight**: ~4845.5 g/mol
• **Net Peptide Content**: Verified via elemental nitrogen analysis
• **Form**: White Lyophilized Cake
• **Sterility**: 0.22 ??m sterile-filtered prior to lyophilization
### Storage Guidelines
• **Lyophilized Powder**: Store at -20??C in the dark. Stable up to 36 months sealed.
• **Reconstituted Solution**: Refrigerate at 2??C to 8??C. Utilize within 28 days of reconstitution.
Certificate of Analysis (CoA)
Lot-specific analytical documentation verified via Reverse-Phase HPLC and Mass Spectrometry for Retatrutide 30 MG. Confirms purity, sequence identity, and laboratory-grade compliance.


